Yuqi Dong1, Linlin Wang1, Yunping Lei2, Na Yang1, Robert M Cabrera2, Richard H Finnell2, Aiguo Ren1. 1. Institute of Reproductive and Child Health, Ministry of Health Key Laboratory of Reproductive Health, Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China. 2. Departments of Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, Texas.
Abstract
BACKGROUND: Folate receptors (FRs) facilitate embryonic uptake of folates and are important for proper early embryonic development. There is accumulating evidence that blocking FR autoantibodies contribute to developmental diseases. However, genetic factors associated with the expression of FR autoantibodies remain unknown. OBJECTIVE: We investigated the effects of genetic polymorphisms in folate pathway genes on FR autoantibody titers in women. METHODS: We recruited 302 pregnant women in China. The FR antigen-down immunoassay was used to measure levels of FR autoantibodies including human immunoglobulin G (IgG) and immunoglobulin M (IgM) in maternal plasma. Genotypes were identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry and polymerase chain reaction methods. General linear model was used to analyze the effects of genetic variants on FR autoantibody levels. RESULTS: Significant associations were observed between genotypic variations and levels of FR autoantibodies. Plasma levels of FR autoantibodies in women with the TT genotype at MTHFR rs1801133 were significantly higher than those of women with the CC genotype (IgG: β = 0.62, 95% CI 0.21-1.04; IgM: β = 0.42, 95% CI 0.12-0.72). For DNMT3A rs7560488, the level of FR autoantibody IgG significantly increased in the TT genotype compared with CC genotype (β = 0.90, 95% CI 0.20-1.59). For MTHFD2 rs828903, genotype GG was associated with elevated levels of FR autoantibody IgM compared to the AA genotype (β = 0.60, 95% CI 0.10-1.10). No association was detected between genetic variants of the DHFR gene with FR autoantibodies levels. CONCLUSION: Genetic variations in MTHFR, DNMT3A, and MTHFD2 genes were associated with elevated plasma levels of FR autoantibodies.
BACKGROUND:Folate receptors (FRs) facilitate embryonic uptake of folates and are important for proper early embryonic development. There is accumulating evidence that blocking FR autoantibodies contribute to developmental diseases. However, genetic factors associated with the expression of FR autoantibodies remain unknown. OBJECTIVE: We investigated the effects of genetic polymorphisms in folate pathway genes on FR autoantibody titers in women. METHODS: We recruited 302 pregnant women in China. The FR antigen-down immunoassay was used to measure levels of FR autoantibodies including human immunoglobulin G (IgG) and immunoglobulin M (IgM) in maternal plasma. Genotypes were identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry and polymerase chain reaction methods. General linear model was used to analyze the effects of genetic variants on FR autoantibody levels. RESULTS: Significant associations were observed between genotypic variations and levels of FR autoantibodies. Plasma levels of FR autoantibodies in women with the TT genotype at MTHFR rs1801133 were significantly higher than those of women with the CC genotype (IgG: β = 0.62, 95% CI 0.21-1.04; IgM: β = 0.42, 95% CI 0.12-0.72). For DNMT3Ars7560488, the level of FR autoantibody IgG significantly increased in the TT genotype compared with CC genotype (β = 0.90, 95% CI 0.20-1.59). For MTHFD2rs828903, genotype GG was associated with elevated levels of FR autoantibody IgM compared to the AA genotype (β = 0.60, 95% CI 0.10-1.10). No association was detected between genetic variants of the DHFR gene with FR autoantibodies levels. CONCLUSION: Genetic variations in MTHFR, DNMT3A, and MTHFD2 genes were associated with elevated plasma levels of FR autoantibodies.
Authors: J A Piedrahita; B Oetama; G D Bennett; J van Waes; B A Kamen; J Richardson; S W Lacey; R G Anderson; R H Finnell Journal: Nat Genet Date: 1999-10 Impact factor: 38.330
Authors: N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom Journal: Am J Hum Genet Date: 1998-05 Impact factor: 11.025
Authors: Anne Parle-McDermott; Faith Pangilinan; James L Mills; Peadar N Kirke; Eileen R Gibney; James Troendle; Valerie B O'Leary; Anne M Molloy; Mary Conley; John M Scott; Lawrence C Brody Journal: Am J Med Genet A Date: 2007-06-01 Impact factor: 2.802
Authors: William G Johnson; Edward S Stenroos; John R Spychala; Sansnee Chatkupt; Sue X Ming; Steven Buyske Journal: Am J Med Genet A Date: 2004-02-01 Impact factor: 2.802
Authors: Robert M Cabrera; Jaclyn P Souder; John W Steele; Lythou Yeo; Gabriel Tukeman; Daniel A Gorelick; Richard H Finnell Journal: AIDS Date: 2019-11-01 Impact factor: 4.177
Authors: Xuanye Cao; Annika Wolf; Sung-Eun Kim; Robert M Cabrera; Bogdan J Wlodarczyk; Huiping Zhu; Margaret Parker; Ying Lin; John W Steele; Xiao Han; Vincent Th Ramaekers; Robert Steinfeld; Richard H Finnell; Yunping Lei Journal: J Med Genet Date: 2020-08-20 Impact factor: 6.318